Tu, Thomas http://orcid.org/0000-0002-0482-4387
Article History
First Online: 3 August 2022
Competing interests
: T.T. consults for and advises for Gilead, Excision Biosciences and GlaxoSmithKline and has received research funding from Gilead and Excision Biosciences. T.T. is currently president of the Australian Centre for Hepatitis Virology and founder/director of ExternalRef removed, an online support network for people living with hepatitis B.